BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/21/2020 4:02:08 PM | Browse: 317 | Download: 605
Publication Name World Journal of Hepatology
Manuscript ID 55718
Country/Territory Japan
2020-04-10 06:52
Peer-Review Started
2020-04-10 06:52
To Make the First Decision
Return for Revision
2020-04-26 21:15
2020-07-12 06:58
Second Decision
2020-07-21 09:28
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-07-26 21:30
Articles in Press
2020-07-26 21:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-08-03 19:40
Typeset the Manuscript
2020-09-11 11:43
Publish the Manuscript Online
2020-09-21 16:02
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Prospective Study
Article Title Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
Manuscript Source Invited Manuscript
All Author List Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima, Junpei Okamura, Akira Kawashima, Taisei Nakao, Takeshi Hara, Hiroyoshi Matsutani, Izumi Nishikawa and Katsuhiko Higashi
Author(s) ORCID Number
Hideyuki Tamai http://orcid.org/0000-0003-4511-4573
Naoki Shingaki http://orcid.org/0000-0002-1798-4080
Yoshiyuki Ida http://orcid.org/0000-0001-9698-9439
Ryo Shimizu http://orcid.org/0000-0001-9745-7215
Shuya Maeshima http://orcid.org/0000-0002-7316-3260
Junpei Okamura http://orcid.org/0000-0002-3312-4128
Akira Kawashima http://orcid.org/0000-0001-5345-0732
Taisei Nakao http://orcid.org/0000-0003-4823-3703
Takeshi Hara http://orcid.org/0000-0002-9682-8974
Hiroyoshi Matsutani http://orcid.org/0000-0002-1587-8540
Izumi Nishikawa http://orcid.org/0000-0001-5799-8930
Katsuhiko Higashi http://orcid.org/0000-0001-5931-706X
Funding Agency and Grant Number
Corresponding Author Hideyuki Tamai, MD, PhD, Director, Department of Hepatology, Wakayama Rosai Hospital, 93-1 Kinomoto, Wakayama 6408505, Japan. hdy-tamai@wakayamah.johas.go.jp
Key Words Hepatitis C virus; Genotype 2; Sofosbuvir; Ribavirin; Elderly patients; Cirrhosis
Core Tip This was a multicenter post-marketing prospective cohort study of sofosbuvir plus ribavirin therapy for patients with genotype 2 hepatitis C virus in a real-world clinical setting. Combination therapy using sofosbuvir plus ribavirin was tolerable and highly effective even in elderly patients  75 years old.
Publish Date 2020-09-21 16:02
Citation Tamai H, Shingaki N, Ida Y, Shimizu R, Maeshima S, Okamura J, Kawashima A, Nakao T, Hara T, Matsutani H, Nishikawa I, Higashi K. Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over. World J Hepatol 2020; 12(9): 672-684
URL https://www.wjgnet.com/1948-5182/full/v12/i9/672.htm
DOI https://dx.doi.org/ 10.4254/wjh.v12.i9.672
Full Article (PDF) WJH-12-672.pdf
Full Article (Word) WJH-12-672.docx
Manuscript File 55718-Review-Filipodia.doc
Answering Reviewers 55718-Answering reviewers.pdf
Audio Core Tip 55718-Audio core tip.mp4
Clinical Trial Registration Statement 55718-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form 55718-Conflict-of-interest statement.pdf
Copyright License Agreement 55718-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 55718-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 55718-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate 55718-Language certificate.pdf
Peer-review Report 55718-Peer-review(s).pdf
Scientific Misconduct Check 55718-Scientific misconduct check.pdf
Scientific Editor Work List 55718-Scientific editor work list.pdf